Understanding Basal Cell Carcinoma: Why Early Treatment Matters

London Dermatology | 9 April 2025

At Devonshire Dermatology, we believe that education and early detection are key to protecting your skin health. Basal cell carcinoma (BCC) is the most common type of skin cancer, and understanding it can make all the difference in ensuring successful treatment.

BCC arises from the basal cells, which sit at the bottom of the skin’s outermost layer. Their role is to create new skin cells as old ones die off. However, when basal cells become abnormal — often due to sun damage sustained decades earlier— they can form a cancerous lesion. People with fair skin are particularly at risk, especially those with a history of frequent sun exposure.

Although basal cell carcinoma grows slowly and does not spread to other parts of the body, it is far from harmless. Left untreated, BCC can burrow deep into the skin, causing significant damage to skin, tissue, and even bone. This can result in ulcers and disfigurement that require more extensive treatment.

Fortunately, the solution is straightforward. Surgical treatment of basal cell carcinoma is simple, highly effective, and curative. In most cases, it can be performed as a walk-in, walk-out procedure under local anaesthetic, minimising downtime and ensuring rapid recovery.

At Devonshire Dermatology, our expert team, led by Dr. Christopher Rowland Payne, offers precise diagnosis and state-of-the-art treatment options to manage BCC effectively. Regular skin checks and prompt treatment are your best defence against this common cancer.

If you notice a suspicious spot or persistent sore on your skin, don’t delay. Contact us today to arrange a consultation with one of our specialist dermatologists. Your skin health is our priority — and early action can save more than just your skin.